Merck & Co Inc - Company Profile

Powered by

All the data and insights you need on Merck & Co Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Merck & Co Inc Strategy Report

  • Understand Merck & Co Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Merck & Co Inc (Merck) is a biopharmaceutical company focused on the discovery, development, manufacturing and marketing of prescription medicines, biologic therapies, vaccines, and animal health products. It offers prescription products for therapy areas related to cardiovascular, cancer, immune disorders, infectious, respiratory, and diabetes. The company provides animal health products such as vaccines, poultry products, livestock products and aquaculture products. Merck sells medicines to drug wholesalers, retailers, hospitals, government agencies and managed health care providers; and animal health products to veterinarians, distributors and animal producers. The company and its subsidiaries operate in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America. Merck is known as MSD outside the US and Canada and is headquartered in Kenilworth, New Jersey, the US.

Gain a 360-degree view of Merck & Co Inc and make more informed decisions for your business Gain a 360-degree view of Merck & Co Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 2000 Galloping Hill Road, Kenilworth, New Jersey, 07033


Telephone 1 908 7404000

No of Employees 72,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange MRK (NYSE)

Revenue (2023) $60.1B

EPS XYZ

Market Cap* $307.8B

Net Profit Margin (2023) XYZ -97.5%

   

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Merck & Co Inc premium industry data and analytics

5,000+

Clinical Trials

Determine Merck & Co Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2,400+

Catalyst Calendar

Proactively evaluate Merck & Co Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

2,000+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Merck & Co Inc’s relevant decision makers and contact details.

880+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

840+

Pipeline Drugs

Identify which of Merck & Co Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

390+

Marketed Drugs

Understand Merck & Co Inc’s commercialized product portfolio to stay one step ahead of the market.

140+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Merck & Co Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

120+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Investigators

Review investigator profiles and find information on trial contacts across Merck & Co Inc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

4

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Merck & Co Inc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Brands
- -
Vaccine: Zetia
Influenza Virus Vaccine Vytorin
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Merck & Co Inc portfolio and identify potential areas for collaboration Understand Merck & Co Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Contracts/Agreements In March, the company entered into an agreement with IDEAYA Biosciences to appraise IDE161 in combination with KEYTRUDA.
2024 Acquisitions/Mergers/Takeovers In March, the company completed the acquisition of Harpoon Therapeutics, Inc.
2024 Contracts/Agreements In January, the company entered into an agreement with LAVA Therapeutics to estimate its anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207 for patients with therapy refractory metastatic castration-resistant prostate cancer.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Merck & Co Inc Johnson & Johnson Pfizer Inc AbbVie Inc Sanofi
Headquarters United States of America United States of America United States of America United States of America France
City Kenilworth New Brunswick New York North Chicago Paris
State/Province New Jersey New Jersey New York Illinois Ile-de-France
No. of Employees 72,000 131,900 88,000 50,000 87,994
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Robert M. Davis President; Chief Executive Officer; Chairman Executive Board 2022 56
Caroline Litchfield Executive Vice President; Chief Financial Officer Senior Management 2021 54
Michael Klobuchar Chief Strategy Officer; Executive Vice President Senior Management 2021 47
Eliav Barr Chief Medical Officer; Head - Global Clinical Development Senior Management 2022 -
Lisa LeCointe-Cephas Chief Ethics and Compliance Officer; Senior Vice President Senior Management 2021 41
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Merck & Co Inc key executives to enhance your sales strategy Gain insight into Merck & Co Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward